AppBlogHilfeonvista bank
Werbung ausblenden
Aktie • Biotechnologie

REATA PHARMACEUTICALS

WKN
A2ALQV
Ticker
RETA
• 2R3
ISIN
US75615P1030
Marktkapitalisierung
–
Dividendenrendite
–
KGV
–
Gewinn pro Aktie
–
Vola 30 Tage
–
theScreener Rating

Unternehmens­daten

Stammdaten zu REATA PHARMACEUTICALS

WKN
A2ALQV
ISIN
US75615P1030
Home-Symbol
RETA
Symbol
2R3
Branche
Biotechnologie
Sektor
Chemie / Pharma / Gesundheit
Unternehmen
Land

Marktdaten

Marktkapitalisierung
–
Anzahl Aktien
–
Streubesitz
–

Mitglieder & Anteilseigner

Anteilseigner

Biogen, Inc.CPMG, Inc.The Vanguard Group, Inc.BlackRock Fund AdvisorsAdage Capital Management LPWellington Management Co. LLPDWS Investment GmbHFirst Light Asset Management LLCBoxer Capital LLCJanus Henderson Investors US LLCEvelyn Potter Rose Survivor's TrustSSgA Funds Management, Inc.Perceptive Advisors LLCHolocene Advisors, LPGeode Capital Management LLCCitadel Advisors LLCPoint72 Asset Management LPMillennium Management LLCFarallon Capital Management LLCFred Alger Management LLC
  • Biogen, Inc. (12,05 %)
  • CPMG, Inc. (8,62 %)
  • The Vanguard Group, Inc. (8,26 %)
  • BlackRock Fund Advisors (5,99 %)
  • Adage Capital Management LP (5,26 %)
  • Wellington Management Co. LLP (4,38 %)
  • DWS Investment GmbH (4,36 %)
  • First Light Asset Management LLC (4,26 %)
  • Boxer Capital LLC (4,26 %)
  • Janus Henderson Investors US LLC (3,09 %)
  • Evelyn Potter Rose Survivor's Trust (2,62 %)
  • SSgA Funds Management, Inc. (2,12 %)
  • Perceptive Advisors LLC (2,00 %)
  • Holocene Advisors, LP (1,99 %)
  • Geode Capital Management LLC (1,77 %)
  • Citadel Advisors LLC (1,70 %)
  • Point72 Asset Management LP (1,69 %)
  • Millennium Management LLC (1,66 %)
  • Farallon Capital Management LLC (1,34 %)
  • Fred Alger Management LLC (1,21 %)

Kontakt

Werbung ausblenden